A Comparative Review of Vitamin E and Associated Equine Disorders

Journal of Veterinary Internal Medicine

Volumn 26, Issue 6, 2012, Pages 1251-1266

  Finno, C J ^a   Valberg, S J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Genetics; Neurology; Neuromuscular disorders; Nutrition; Spinal cord disease

Indexed keywords

EQUIDAE;

EID: 84869870746     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2012.00994.x     Document Type: Review

References (165)

1. Evans HM, Bishop KS. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 1922;56:650-651.
2. Schneider C. Chemistry and biology of vitamin E. Mol Nutr Food Res 2005;49:7-30.
3. McLaughlin PJ, Weihrauch JL. Vitamin E content of foods. J Am Diet Assoc 1979;75:647-665.
4. Mustacich DJ, Bruno RS, Traber MG. Vitamin E. Vitam Horm 2007;76:1-21.
5. Traber MG, Burton GW, Hamilton RL. Vitamin E trafficking. Ann N Y Acad Sci 2004;1031:1-12.
6. Vatassery GT, Adityanjee, Quach HT, et al. Alpha and gamma tocopherols in cerebrospinal fluid and serum from older, male, human subjects. J Am Coll Nutr 2004;23:233-238.
7. Sen CK, Khanna S, Rink C, Roy S. Tocotrienols: The emerging face of natural vitamin E. Vitam Horm 2007;76:203-261.
8. Quinn PJ. Molecular associations of vitamin E. Vitam Horm 2007;76:67-98.
9. Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: Induction, repair and significance. Mutat Res 2004;567:1-61.
10. Meagher EA, Barry OP, Lawson JA, et al. Effects of vitamin E on lipid peroxidation in healthy persons. J Am Med Assoc 2001;285:1178-1182.
11. Princen HM, van Duyvenvoorde W, Buytenhek R, et al. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol 1995;15:325-333.
12. Williams CA, Carlucci SA. Oral vitamin E supplementation on oxidative stress, vitamin and antioxidant status in intensely exercised horses. Equine Vet J Suppl 2006;36:617-621.
13. Avellini L, Chiaradia E, Gaiti A. Effect of exercise training, selenium and vitamin E on some free radical scavengers in horses (Equus caballus). Comp Biochem Physiol B Biochem Mol Biol 1999;123:147-154.
14. Gohil K, Godzdanker R, O'Roark E, et al. Alpha-tocopherol transfer protein deficiency in mice causes multi-organ deregulation of gene networks and behavioral deficits with age. Ann N Y Acad Sci 2004;1031:109-126.
15. Pekmezci D. Vitamin E and immunity. Vitam Horm 2011;86:179-215.
16. Meydani SN, Meydani M, Barklund PM, et al. Effect of vitamin E supplementation on immune responsiveness of the aged. Ann N Y Acad Sci 1989;570:283-290.
17. Gyang EO, Stevens JB, Olson WG, et al. Effects of selenium-vitamin E injection on bovine polymorphonucleated leukocytes phagocytosis and killing of Staphylococcus aureus. Am J Vet Res 1984;45:175-177.
18. Politis I, Hidiroglou M, Batra TR, et al. Effects of vitamin E on immune function of dairy cows. Am J Vet Res 1995;56:179-184.
19. Verdonck F, Merlevede I, Goddeeris BM, et al. Vitamin E deficiency and decreased serum immunoglobulin concentrations in a population of donkeys. Vet Rec 2007;160:232-233.
20. Finch JM, Turner RJ. Effects of selenium and vitamin E on the immune responses of domestic animals. Res Vet Sci 1996;60:97-106.
21. Baalsrud KJ, Overnes G. Influence of vitamin E and selenium supplement on antibody production in horses. Equine Vet J 1986;18:472-474.
22. Petersson KH, Burr DB, Gomez-Chiarri M, Petersson-Wolfe CS. The influence of vitamin E on immune function and response to vaccination in older horses. J Anim Sci 2010;88:2950-2958.
23. NRC. Nutrient Requirements of Horses, 6th ed. Washington, DC: National Research Council; 2007.
24. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 2005;3:28.
25. Agarwal A, Saleh RA. Role of oxidants in male infertility: Rationale, significance, and treatment. Urol Clin North Am 2002;29:817-827.
26. Kontic-Vucinic O, Terzic M, Radunovic N. The role of antioxidant vitamins in hypertensive disorders of pregnancy. J Perinat Med 2008;36:282-290.
27. Almeida J, Ball BA. Effect of alpha-tocopherol and tocopherol succinate on lipid peroxidation in equine spermatozoa. Animal Reprod Sci 2005;87:321-337.
28. Ozer NK, Negis Y, Aytan N, et al. Vitamin E inhibits CD36 scavenger receptor expression in hypercholesterolemic rabbits. Atherosclerosis 2006;184:15-20.
29. Aratri E, Spycher SE, Breyer I, Azzi A. Modulation of alpha-tropomyosin expression by alpha-tocopherol in rat vascular smooth muscle cells. FEBS Lett 1999;447:91-94.
30. Chojkier M, Houglum K, Lee KS, Buck M. Long- and short-term d-alpha-tocopherol supplementation inhibits liver collagen alpha1(I) gene expression. Am J Physiol 1998;275:G1480-G1485.
31. Schindler R, Mentlein R. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J Nutr 2006;136:1477-1482.
32. Glauert HP. Vitamin E and NF-kappaB activation: A review. Vitam Horm 2007;76:135-153.
33. Marsh SA, Coombes JS. Vitamin E and alpha-lipoic acid supplementation increase bleeding tendency via an intrinsic coagulation pathway. Clin Appl Thromb Hemost 2006;12:169-173.
34. Murphy N, Grimsditch DC, Vidgeon-Hart M, et al. Dietary antioxidants decrease serum soluble adhesion molecule (sVCAM-1, sICAM-1) but not chemokine (JE/MCP-1, KC) concentrations, and reduce atherosclerosis in C57BL but not apoE*3 Leiden mice fed an atherogenic diet. Dis Markers 2005;21:181-190.
35. Einarson L. Deposits of fluorescent acid-fast products in the nervous system and skeletal muscles of adult rats with chronic vitamin-E deficiency. J Neurol Neurosurg Psychiatry 1953;16:98-109.
36. Pillai SR, Traber MG, Kayden HJ, et al. Concomitant brainstem axonal dystrophy and necrotizing myopathy in vitamin E-deficient rats. J Neurol Sci 1994;123:64-73.
37. Yokota T, Uchihara T, Kumagai J, et al. Postmortem study of ataxia with retinitis pigmentosa by mutation of the alpha-tocopherol transfer protein gene. J Neurol Neurosurg Psychiatry 2000;68:521-525.
38. Larnaout A, Belal S, Zouari M, et al. Friedreich's ataxia with isolated vitamin E deficiency: A neuropathological study of a Tunisian patient. Acta Neuropathol 1997;93:633-637.
39. Perlson E, Maday S, Fu MM, et al. Retrograde axonal transport: Pathways to cell death? Trends Neurosci 2010;33:335-344.
40. Nell S, Bahtz R, Bossecker A, et al. PCR-verified microarray analysis and functional in vitro studies indicate a role of alpha-tocopherol in vesicular transport. Free Radic Res 2007;41:930-942.
41. Muller DP. Vitamin E and neurological function. Mol Nutr Food Res 2010;54:710-718.
42. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
43. Gurney ME, Cutting FB, Zhai P, et al. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu. Zn superoxide dismutase. Pathol Biol (Paris) 1996;44:51-56.
44. Wang H, O'Reilly EJ, Weisskopf MG, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis: A pooled analysis of data from 5 prospective cohort studies. Am J Epidemiol 2011;173:595-602.
45. Clarkson PM. Antioxidants and physical performance. Crit Rev Food Sci Nutr 1995;35:131-141.
46. Powers SK, DeRuisseau KC, Quindry J, Hamilton KL. Dietary antioxidants and exercise. J Sports Sci 2004;22:81-94.
47. Jenkins RR. Exercise and oxidative stress methodology: A critique. Am J Clin Nutr 2000;72:670S-674S.
48. Ristow M, Zarse K, Oberbach A, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A 2009;106:8665-8670.
49. Petersson K, Hintz HF, Schryver HF, et al. The effect of vitamin E on membrane intregrity during sub-maximal exercise. In: Persson SGB, Lindholm CA, Jeffcolt LB, eds. Equine Exercise Physiology 3. Davis, CA: ICEEP Publication; Stockholm, 1991:315-322.
50. Williams CA, Kronfeldt DS, Hess TM, et al. Antioxidant supplementation and subsequent oxidative stress of horses during an 80-km endurance race. J Anim Sci 2004;82:588-594.
51. Williams CA, Kronfeld DS, Tess TM, et al. Lipoic acid and vitamin E supplementation in horses diminishes endurance exercise induced oxidative stress, muscle enzyme leakage, and apoptosis. Oslo, Norway: Conference on Equine Sports Medicine and Science; 2004:105-119.
52. McMeniman NP, Hintz HF. Effect of vitamin E status on lipid peroxidation in exercised horses. Equine Vet J 1992;24:482-484.
53. Williams CA. Antioxidant Status in Horses Competing in the Jersey Fresh CCI**and CCI*** Three-day-Event. Hunt Valley, MD: 20th Equine Science Society; 2007: 85-86.
54. McDowell LR. Vitamin E. In: McDowell LR, ed. Vitamins in Animal Nutrition. San Diego, CA: Academic Press, Inc; 1989:93-131.
55. Bruhn JC, Oliver JC. Effect of storage on tocopherol and carotene concentrations in alfalfa hay. J Dairy Sci 1978;61:980-982.
56. Maenpaa PH, Lappetelainen R, Virkkunen J. Serum retinol, 25-hydroxyvitamin D and alpha-tocopherol of racing trotters in Finland. Equine Vet J 1987;19:237-240.
57. Maenpaa PH, Koskinen T, Koskinen E. Serum profiles of vitamins A, E and D in mares and foals during different seasons. J Anim Sci 1988;66:1418-1423.
58. Craig AM, Blythe LL, Lassen ED, et al. Variations of serum vitamin E, cholesterol, and total serum lipid concentrations in horses during a 72-hour period. Am J Vet Res 1989;50:1527-1531.
59. Lindholm A, Asheim A. Vitamin E and certain muscular enzymes in the blood serum of horses. Acta Agric Scand Suppl. 1973;19:40-42.
60. Roneus BO, Hakkarainen RV, Lindholm CA, et al. Vitamin E requirements of adult Standardbred horses evaluated by tissue depletion and repletion. Equine Vet J 1986;18:50-58.
61. Higgins JK, Puschner B, Kass PH, Pusterla N. Assessment of vitamin E concentrations in serum and cerebrospinal fluid of horses following oral administration of vitamin E. Am J Vet Res 2008;69:785-790.
62. Pusterla N, Puschner B, Steidl S, et al. Alpha-tocopherol concentrations in equine serum and cerebrospinal fluid after vitamin E supplementation. Vet Rec 2010;166:366-368.
63. Zingg JM, Azzi A, Meydani M. Genetic polymorphisms as determinants for disease-preventive effects of vitamin E. Nutr Rev 2008;66:406-414.
64. Reboul E, Klein A, Bietrix F, et al. Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. J Biol Chem 2006;281:4739-4745.
65. Traber MG, Kayden HJ. Preferential incorporation of alpha-tocopherol vs gamma-tocopherol in human lipoproteins. Am J Clin Nutr 1989;49:517-526.
66. Traber MG, Olivecrona T, Kayden HJ. Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro. J Clin Invest 1985;75:1729-1734.
67. Sattler W, Levak-Frank S, Radner H, et al. Muscle-specific overexpression of lipoprotein lipase in transgenic mice results in increased alpha-tocopherol levels in skeletal muscle. Biochem J 1996;318(Pt 1):15-19.
68. Stahl W, van den Berg H, Arthur J, et al. Bioavailability and metabolism. Mol Aspects Med 2002;23:39-100.
69. Kostner GM, Oettl K, Jauhiainen M, et al. Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells. Biochem J 1995;305(Pt 2):659-667.
70. Desrumaux C, Risold PY, Schroeder H, et al. Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice. FASEB J 2005;19:296-297.
71. Drouineaud V, Lagrost L, Klein A, et al. Phospholipid transfer protein deficiency reduces sperm motility and impairs fertility of mouse males. FASEB J 2006;20:794-796.
72. Panagabko C, Morley S, Hernandez M, et al. Ligand specificity in the CRAL-TRIO protein family. Biochemistry 2003;42:6467-6474.
73. Qian J, Morley S, Wilson K, et al. Intracellular trafficking of vitamin E in hepatocytes: The role of tocopherol transfer protein. J Lipid Res 2005;46:2072-2082.
74. Manor D, Morley S. The alpha-tocopherol transfer protein. Vitam Horm 2007;76:45-65.
75. Shichiri M, Takanezawa Y, Rotzoll DE, et al. ATP-binding cassette transporter A1 is involved in hepatic alpha-tocopherol secretion. J Nutr Biochem 2010;21:451-456.
76. Orso E, Broccardo C, Kaminski WE, et al. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat Genet 2000;24:192-196.
77. Hosomi A, Goto K, Kondo H, et al. Localization of alpha-tocopherol transfer protein in rat brain. Neurosci Lett 1998;256:159-162.
78. Kaempf-Rotzoll DE, Igarashi K, Aoki J, et al. Alpha-tocopherol transfer protein is specifically localized at the implantation site of pregnant mouse uterus. Biol Reprod 2002;67:599-604.
79. Mardones P, Strobel P, Miranda S, et al. Alpha-tocopherol metabolism is abnormal in scavenger receptor class B type I (SR-BI)-deficient mice. J Nutr 2002;132:443-449.
80. Manor D, Atkinson J. Is tocopherol associated protein a misnomer? J Nutr Biochem 2003;14:421-422; author reply 423.
81. Traber MG. Vitamin E nuclear receptors and xenobiotic metabolism. Arch Biochem Biophys 2004;423:6-11.
82. Goti D, Balazs Z, Panzenboeck U, et al. Effects of lipoprotein lipase on uptake and transcytosis of low density lipoprotein (LDL) and LDL-associated alpha-tocopherol in a porcine in vitro blood-brain barrier model. J Biol Chem 2002;277:28537-28544.
83. Cohn W, Kuhn H. The role of the low density lipoprotein receptor for alpha-tocopherol delivery to tissues. Ann N Y Acad Sci 1989;570:61-71.
84. Goti D, Hrzenjak A, Levak-Frank S, et al. Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E. J Neurochem 2001;76:498-508.
85. Heiser M, Hutter-Paier B, Jerkovic L, et al. Vitamin E binding protein afamin protects neuronal cells in vitro. J Neural Transm Suppl 2002;62:337-345.
86. Vatassery GT, Lam C, Smith WE, Quach HT. Apolipoprotein E exerts selective and differential control over vitamin E concentrations in different areas of mammalian brain. J Neurosci Res 2006;84:1335-1342.
87. Traber MG, Kayden HJ. Tocopherol distribution and intracellular localization in human adipose tissue. Am J Clin Nutr 1987;46:488-495.
88. Kluth D, Landes N, Pfluger P, et al. Modulation of Cyp3a11 mRNA expression by alpha-tocopherol but not gamma-tocotrienol in mice. Free Radic Biol Med 2005;38:507-514.
89. Mustacich DJ, Shields J, Horton RA, et al. Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice. Arch Biochem Biophys 1998;350:183-192.
90. Blatt DH, Pryor WA, Mata JE, Rodriguez-Proteau R. Re-evaluation of the relative potency of synthetic and natural alpha-tocopherol: Experimental and clinical observations. J Nutr Biochem 2004;15:380-395.
91. Kane E, Stuart RL, Pusterla N. Influence of source and quantity of supplemental vitamin E on equine serum and cerebrospinal fluid alpha-tocopherol and its implication for neurologic diseases. In: Proceedings of 56th Annual Convention of the American Association of Equine Practitioners. Baltimore, MD: American Association of Equine Practitioners; 2010:343-347.
92. Liu SK, Dolensek EP, Adams CR, et al. Myelopathy and vitamin E deficiency in six Mongolian wild horses. J Am Vet Med Assoc 1983;183:1266-1268.
93. Dju MY, Mason KE, Filer LJ Jr. Vitamin E (tocopherol) in human tissues from birth to old age. Am J Clin Nutr 1958;6:50-60.
94. Steiss JE, Traber MG, Williams MA, et al. Alpha tocopherol concentrations in clinically normal adult horses. Equine Vet J 1994;26:417-419.
95. Divers T, De Lahunta A, Hintz HF, et al. Equine motor neuron disease. Equine Vet Educ 2001;13:63-67.
96. Dierenfeld ES, Hoppe PP, Woodford MH, et al. Plasma alpha-tocopherol, beta-carotene, and lipid levels in semi-free-ranging Przewalski horses (Equus przewalskii). J Zoo Wildl Med 1997;28:144-147.
97. Maenpaa PH, Pirhonen A, Koskinen E. Vitamin A, E and D nutrition in mares and foals during the winter season: Effect of feeding two different vitamin-mineral concentrates. J Anim Sci 1988;66:1424-1429.
98. Schweigert FJ, Gottwald C. Effect of parturition on levels of vitamins A and E and of beta-carotene in plasma and milk of mares. Equine Vet J 1999;31:319-323.
99. Muirhead TL, Wichtel JJ, Stryhn H, McClure JT. The selenium and vitamin E status of horses in Prince Edward Island. Can Vet J 2010;51:979-985.
100. Vanschandevijl K, Nollet H, Deprez P, et al. Variation in deficient serum vitamin E levels and impact on assessment of the vitamin E status in horses. Vlaams Diergeneeskunidig Tijdschrift 2008;78:28-33.
101. Traber MG, Ramakrishnan R, Kayden HJ. Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR-alpha-tocopherol. Proc Natl Acad Sci U S A 1994;91:10005-10008.
102. de Moffarts BK, Kirschvink N, Art T, et al. Impact of training and exercise intensity on blood antioxidant markers in healthy Standardbred horses. Equine Comp Exerc Physiol 2004; 1(3):211-220.
103. Craig AM, Blythe LL, Rowe KE, et al. Variability of alpha-tocopherol values associated with procurement, storage, and freezing of equine serum and plasma samples. Am J Vet Res 1992;53:2228-2234.
104. Thurnham DI, Flora PS. Stability of individual carotenoids, retinol, and tocopherol in stored plasma. Clin Chem 1988;34:1947.
105. Traber MG, Sokol RJ, Ringel SP, et al. Lack of tocopherol in peripheral nerves of vitamin E-deficient patients with peripheral neuropathy. N Engl J Med 1987;317:262-265.
106. Horwitt MK, Harvey CC, Dahm CH Jr, Searcy MT. Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. Ann N Y Acad Sci 1972;203:223-236.
107. Combs GF. Mechanisms of absorption, transport and tissue uptake of vitamin E. In: Coelho MB, ed. Vitamin E in Animal Nutrition and Management. Georgetown, Ontario: BASF Canada Inc; 1991:19-27.
108. Ingold KU, Burton GW, Foster DO, et al. Biokinetics of and discrimination between dietary RRR- and SRR-alpha-tocopherols in the male rat. Lipids 1987;22:163-172.
109. Vatassery GT, Brin MF, Fahn S, et al. Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissue of rats. J Neurochem 1988;51:621-623.
110. Vatassery GT, Nelson MJ, Maletta GJ, Kuskowski MA. Vitamin E (tocopherols) in human cerebrospinal fluid. Am J Clin Nutr 1991;53:95-99.
111. Narcisi TM, Shoulders CC, Chester SA, et al. Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia. Am J Hum Genet 1995;57:1298-1310.
112. Muller DP, Harries JT, Lloyd JK. The relative importance of the factors involved in the absorption of vitamin E in children. Gut 1974;15:966-971.
113. Ouahchi K, Arita M, Kayden H, et al. Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet 1995;9:141-145.
114. Gotoda T, Arita M, Arai H, et al. Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein. N Engl J Med 1995;333:1313-1318.
115. Traber MG, Sokol RJ, Kohlschutter A, et al. Impaired discrimination between stereoisomers of alpha-tocopherol in patients with familial isolated vitamin E deficiency. J Lipid Res 1993;34:201-210.
116. Cummings JF, de Lahunta A, George C, et al. Equine motor neuron disease: A preliminary report. Cornell Vet 1990;80:357-379.
117. Divers TJ, Mohammed HO, Cummings JF, et al. Equine motor neuron disease: Findings in 28 horses and proposal of a pathophysiological mechanism for the disease. Equine Vet J 1994;26:409-415.
118. Divers TJ, Valentine BA, Jackson CA, et al. Simple and Practical Muscle Biopsy Test for Equine Motor Neuron Disease. 42nd Annual American Association of Equine Practitioners; 1996;180-181.
119. Jackson CA, De Lahunta A, Cummings JF, et al. Spinal accessory nerve biopsy as an antemortem diagnostic test for equine motor neuron disease. Equine Vet J 1996;28:215-219.
120. Divers TJ, Cummings JE, de Lahunta A, et al. Evaluation of the risk of motor neuron disease in horses fed a diet low in vitamin E and high in copper and iron. Am J Vet Res 2006;67:120-126.
121. de la Rua-Domenech R, Mohammed HO, Cummings JF, et al. Intrinsic, management, and nutritional factors associated with equine motor neuron disease. J Am Vet Med Assoc 1997;211:1261-1267.
122. Mohammed HO, Cummings JF, Divers TJ, et al. Risk factors associated with equine motor neuron disease: A possible model for human MND. Neurology 1993;43:966-971.
123. Mohammed HO, Starkey SR, Stipetic K, et al. The role of dietary antioxidant insufficiency on the permeability of the blood-brain barrier. J Neuropathol Exp Neurol 2008;67:1187-1193.
124. Radunovic A, Leigh PN. ALSODatabase: Database of SOD1 (and other) gene mutations in ALS on the Internet. European FALS Group and ALSOD Consortium. Amyotroph Lateral Scler Other Motor Neuron Disord 1999;1:45-49.
125. de la Rua-Domenech R, Wiedmann M, Mohammed HO, et al. Equine motor neuron disease is not linked to Cu/Zn superoxide dismutase mutations: Sequence analysis of the equine Cu/Zn superoxide dismutase cDNA. Gene 1996;178:83-88.
126. Beech J. Neuroaxonal dystrophy of the accessory cuneate nucleus in horses. Vet Pathol 1984;21:384-393.
127. Baumgartner W, Frese K, Elmadfa I. Neuroaxonal dystrophy associated with vitamin E deficiency in two Haflinger horses. J Comp Pathol 1990;103:114-119.
128. Gandini G, Fatzer R, Mariscoli M, et al. Equine degenerative myeloencephalopathy in five Quarter Horses: Clinical and neuropathological findings. Equine Vet J 2004;36:83-85.
129. Mayhew IG, de Lahunta A, Whitlock RH, Geary JC. Equine degenerative myeloencephalopathy. J Am Vet Med Assoc 1977;170:195-201.
130. Blythe LL, Hultgren BD, Craig AM, et al. Clinical, viral, and genetic evaluation of equine degenerative myeloencephalopathy in a family of Appaloosas. J Am Vet Med Assoc 1991;198:1005-1013.
131. Dill SG, Kallfelz FA, deLahunta A, Waldron CH. Serum vitamin E and blood glutathione peroxidase values of horses with degenerative myeloencephalopathy. Am J Vet Res 1989;50:166-168.
132. Aleman M, Finno CJ, Higgins RJ, et al. Evaluation of epidemiological, clinical, and pathological features of neuroaxonal dystrophy in Quarter Horses. J Am Vet Med Assoc 2011;239:823-833.
133. Mayhew IG, Brown CM, Stowe HD, et al. Equine degenerative myeloencephalopathy: A vitamin E deficiency that may be familial. J Vet Intern Med 1987;1:45-50.
134. Mayhew IG, de Lahunta A, Whitlock RH, et al. Spinal cord disease in the horse. Cornell Vet 1978;68(Suppl 6):1-207.
135. Beech J, Haskins M. Genetic studies of neuraxonal dystrophy in the Morgan. Am J Vet Res 1987;48:109-113.
136. Finno CJ, Higgins RJ, Aleman M, et al. Equine degenerative myeloencephalopathy in lusitano horses. J Vet Intern Med 2011;25:1439-1446.
137. Cummings JF, de Lahunta A, Mohammed HO, et al. Endothelial lipopigment as an indicator of alpha-tocopherol deficiency in two equine neurodegenerative diseases. Acta Neuropathol 1995;90:266-272.
138. Blythe LL, Craig AM. Equine degenerative myelencephalopathy: Part I. clinical signs and pathogenesis. Comp Cont Educ Pract Vet 1992;14:1215-1221.
139. Adams AP, Collatos C, Fuentealba C, et al. Neuroaxonal dystrophy in a two-year-old Quarter horse filly. Can Vet J 1996;37:43-44.
140. Dill SG, Correa MT, Erb HN, et al. Factors associated with the development of equine degenerative myeloencephalopathy. Am J Vet Res 1990;51:1300-1305.
141. Sokol RJ, Guggenheim MA, Heubi JE, et al. Frequency and clinical progression of the vitamin E deficiency neurologic disorder in children with prolonged neonatal cholestasis. Am J Dis Child 1985;139:1211-1215.
142. Blythe LL, Craig AM, Lassen ED, et al. Serially determined plasma alpha-tocopherol concentrations and results of the oral vitamin E absorption test in clinically normal horses and in horses with degenerative myeloencephalopathy. Am J Vet Res 1991;52:908-911.
143. Lekeux P, Kirschvink N. Antioxidants and horse health. In: Robinson NE, ed. Current Therapy in Equine Medicine, 6th ed. St. Louis, MO: Saunders; 2009:73-78.
144. Bedford H, Valberg SJ, Firshman A, et al. Reversible generalized muscle atrophy and weakness associated with sacrocaudalis dorsalis medialis mitochondrial myopathy and vitamin E deficiency in horses. J Am Vet Med Assoc 2012, in press.
145. Knarreborg A, Lauridsen C, Engberg RM, Jensen SK. Dietary antibiotic growth promoters enhance the bioavailability of alpha-tocopheryl acetate in broilers by altering lipid absorption. J Nutr 2004;134:1487-1492.
146. Pagan JD, Kane E, Nash D. Form and source of tocopherol affects vitamin E status in Thoroughbred horses. Pferdeheikunde 2005;21:101-102.
147. Weber P, Bendich A, Machlin LJ. Vitamin E and human health: Rationale for determining recommended intake levels. Nutrition 1997;13:450-460.
148. Burton GW, Ingold KU, Foster DO, et al. Comparison of free alpha-tocopherol and alpha-tocopheryl acetate as sources of vitamin E in rats and humans. Lipids 1988;23:834-840.
149. Acuff RV, Thedford SS, Hidiroglou NN, et al. Relative bioavailability of RRR- and all-rac-alpha-tocopheryl acetate in humans: Studies using deuterated compounds. Am J Clin Nutr 1994;60:397-402.
150. Mustacich DJ, Vo AT, Elias VD, et al. Regulatory mechanisms to control tissue alpha-tocopherol. Free Radic Biol Med 2007;43:610-618.
151. Kelly FJ, Lee R, Mudway IS. Inter- and intra-individual vitamin E uptake in healthy subjects is highly repeatable across a wide supplementation dose range. Ann N Y Acad Sci 2004;1031:22-39.
152. Pryor WA. Vitamin E and heart disease: Basic science to clinical intervention trials. Free Radic Biol Med 2000;28:141-164.
153. Miller ER 3rd, Pastor-Barriuso R, Dalal D, et al. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005;142:37-46.
154. Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. J Am Med Assoc 2007;297:842-857.
155. Dotan Y, Lichtenberg D, Pinchuk I. No evidence supports vitamin E indiscriminate supplementation. BioFactors 2009;35:469-473.
156. Kliewer SA, Goodwin B, Willson TM. The nuclear pregnane X receptor: A key regulator of xenobiotic metabolism. Endocr Rev 2002;23:687-702.
157. Bertone JJ. Equine Clinical Pharmacology, 1st ed. Philadelphia, PA: Saunders; 2004.
158. Orsini JA, Divers TJ. Manual of Equine Emergencies, 2nd ed. Philadelphia, PA: Saunders; 2003.
159. Stewart RH, Rush BR. Cervical vertebral stenotic myelopathy. In: Reed SM, Bayly WM, Sellon DC, eds. Equine Internal Medicine, 2nd ed. St. Louis, MO: Saunders; 2004:594-598.
160. Shoulson I. DATATOP: A decade of neuroprotective inquiry. Parkinson study group. Deprenyl and tocopherol antioxidative therapy of parkinsonism. Ann Neurol 1998;44:S160-S166.
161. Peyser CE, Folstein M, Chase GA, et al. Trial of d-alpha-tocopherol in Huntington's disease. Am J Psychiatry 1995;152:1771-1775.
162. Blythe LL, Craig AM. Degenerative myeloencephalopathy. In: Robinson NE, ed. Current Therapy in Equine Medicine, 3rd ed. Philadelphia, PA: WB Saunders; 1992:559-561.
163. de Moffarts B, Kirschvink N, Art T, et al. Effect of oral antioxidant supplementation on blood antioxidant status in trained thoroughbred horses. Vet J 2005;169:65-74.
164. Kirschvink N, de Moffarts B, Farnir F, et al. Investigation of blood oxidant/antioxidant markers in healthy competition horses of different breeds. Equine Vet J Supp 2006;36:239-244.
165. Kienzle E, Freismuth A, Reusch A. Double-blind placebo-controlled vitamin E or selenium supplementation of sport horses with unspecified muscle problems. An example of the potential of placebos. J Nutr 2006;136:2045S-2047S.